ONYX PHARMACEUTICALS INC (ONXX) financial statements (2021 and earlier)

Company profile

Business Address 249 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments484
Cash and cash equivalents153
Short-term investments331
Receivables147
Inventory, net of allowances, customer advances and progress billings15
Inventory15
Prepaid expense and other current assets38
Deferred tax assets3
Total current assets:688
Noncurrent Assets
Property, plant and equipment26
Long-term investments and receivables8
Long-term investments8
Intangible assets, net (including goodwill)623
Goodwill194
Intangible assets, net (excluding goodwill)429
Prepaid expense and other noncurrent assets6
Total noncurrent assets:664
TOTAL ASSETS:1,352
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities118
Accounts payable0
Accrued liabilities48
Employee-related liabilities30
Accounts payable and other accrued liabilities40
Deferred revenue and credits10
Other liabilities4
Total current liabilities:131
Noncurrent Liabilities
Long-term debt and lease obligation174
Long-term debt, excluding current maturities174
Liabilities, other than long-term debt77
Deferred tax liabilities, net52
Other liabilities25
Total noncurrent liabilities:251
Total liabilities:382
Stockholders' equity
Stockholders' equity attributable to parent820
Common stock0
Additional paid in capital1,472
Accumulated other comprehensive income0
Accumulated deficit(651)
Receivable from shareholders or affiliates for issuance of capital stock(1)
Total stockholders' equity:820
Other undisclosed liabilities and equity149
TOTAL LIABILITIES AND EQUITY:1,352

Income statement (P&L) ($ in millions)

12/31/2012
Revenues
(Revenue, Net)
362
Cost of revenue
(Cost of Goods and Services Sold)
(1)
Gross profit:361
Operating expenses(629)
Other undisclosed operating income1
Operating loss:(267)
Nonoperating income
(Investment Income, Nonoperating)
3
Interest and debt expense(22)
Other undisclosed income from continuing operations before equity method investments, income taxes2
Loss from continuing operations before income taxes:(285)
Income tax benefit97
Net loss available to common stockholders, diluted:(188)

Comprehensive Income ($ in millions)

12/31/2012
Net loss:(188)
Comprehensive loss:(188)
Other undisclosed comprehensive income, net of tax, attributable to parent2
Comprehensive loss, net of tax, attributable to parent:(186)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: